Cargando…
Bringing precision medicine to the management of pregnancy in women with glucokinase-MODY: a study of diagnostic accuracy and feasibility of non-invasive prenatal testing
AIMS/HYPOTHESIS: In pregnancies where the mother has glucokinase-MODY (GCK-MODY), fetal growth is determined by fetal genotype. When the fetus inherits a maternal pathogenic GCK variant, normal fetal growth is anticipated, and insulin treatment of maternal hyperglycaemia is not recommended. At prese...
Autores principales: | Hughes, Alice E., Houghton, Jayne A. L., Bunce, Benjamin, Chakera, Ali J., Spyer, Gill, Shepherd, Maggie H., Flanagan, Sarah E., Hattersley, Andrew T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542291/ https://www.ncbi.nlm.nih.gov/pubmed/37653058 http://dx.doi.org/10.1007/s00125-023-05982-9 |
Ejemplares similares
-
Glucokinase (GCK) Mutations and Their Characterization in MODY2 Children of Southern Italy
por: Capuano, Marina, et al.
Publicado: (2012) -
Cross-sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia
por: Stride, Amanda, et al.
Publicado: (2013) -
Susceptibility of Glucokinase-MODY Mutants to Inactivation by Oxidative Stress in Pancreatic β-Cells
por: Cullen, Kirsty S., et al.
Publicado: (2011) -
Clinical Heterogeneity in Monogenic Diabetes Caused by Mutations in the Glucokinase Gene (GCK-MODY)
por: Cuesta-Muñoz, Antonio L., et al.
Publicado: (2010) -
Phenotype Heterogeneity in Glucokinase–Maturity-Onset Diabetes of the Young (GCK-MODY) Patients
por: Wędrychowicz, Anna, et al.
Publicado: (2017)